Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
CNY 14.42
(-1.23%)
CNY 14.42
(-1.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -179.94 Million CNY | 79.26% |
| 2022 | -867.65 Million CNY | -83.36% |
| 2021 | -473.21 Million CNY | -143.99% |
| 2020 | -193.94 Million CNY | -93.63% |
| 2019 | -100.16 Million CNY | -114.0% |
| 2018 | -46.8 Million CNY | 61.52% |
| 2017 | -121.63 Million CNY | -581.45% |
| 2016 | -17.84 Million CNY | -179.26% |
| 2015 | 22.52 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -129.51 Million CNY | -43.49% |
| 2024 Q1 | -269.04 Million CNY | -49.51% |
| 2024 Q2 | -87.79 Million CNY | 67.37% |
| 2023 FY | -179.94 Million CNY | 79.26% |
| 2023 Q3 | -338.08 Million CNY | -187.24% |
| 2023 Q2 | -117.7 Million CNY | 40.06% |
| 2023 Q4 | -179.94 Million CNY | 46.78% |
| 2023 Q1 | -196.36 Million CNY | 77.37% |
| 2022 FY | -867.65 Million CNY | -83.36% |
| 2022 Q4 | -867.65 Million CNY | -542.84% |
| 2022 Q3 | -134.97 Million CNY | 36.94% |
| 2022 Q2 | -214.02 Million CNY | 21.58% |
| 2022 Q1 | -272.93 Million CNY | 42.32% |
| 2021 Q3 | -118.19 Million CNY | 38.4% |
| 2021 Q1 | -316.2 Million CNY | -63.04% |
| 2021 FY | -473.21 Million CNY | -143.99% |
| 2021 Q4 | -473.21 Million CNY | -300.36% |
| 2021 Q2 | -191.88 Million CNY | 39.32% |
| 2020 Q2 | -110.39 Million CNY | -129.0% |
| 2020 Q1 | -48.2 Million CNY | 51.87% |
| 2020 FY | -193.94 Million CNY | -93.63% |
| 2020 Q4 | -193.94 Million CNY | -25.99% |
| 2020 Q3 | -153.94 Million CNY | -39.45% |
| 2019 Q1 | 55.1 Million CNY | 217.73% |
| 2019 Q4 | -100.16 Million CNY | 0.0% |
| 2019 FY | -100.16 Million CNY | -114.0% |
| 2018 Q1 | -40.08 Million CNY | 0.0% |
| 2018 Q2 | -40.08 Million CNY | 0.0% |
| 2018 Q4 | -46.8 Million CNY | 0.0% |
| 2018 FY | -46.8 Million CNY | 61.52% |
| 2017 FY | -121.63 Million CNY | -581.45% |
| 2016 FY | -17.84 Million CNY | -179.26% |
| 2015 FY | 22.52 Million CNY | 0.0% |